Thus, high MMP9 expression levels could be associated with the progression from steatosis to NASH and possibly with the progression from NASH to HCC or cirrhosis (Figs. 5A and S6). This evidence concerns the gene MMP9 and metabolic dysfunction-associated steatohepatitis.